Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Net Margin (2016 - 2024)

Avanos Medical's Net Margin history spans 10 years, with the latest figure at 0.94% for Q3 2024.

  • For Q3 2024, Net Margin fell 392.0% year-over-year to 0.94%; the TTM value through Dec 2024 reached 1.08%, up 663.0%, while the annual FY2023 figure was 7.71%, 1195.0% down from the prior year.
  • Net Margin for Q3 2024 was 0.94% at Avanos Medical, up from 1.46% in the prior quarter.
  • Across five years, Net Margin topped out at 20.28% in Q2 2021 and bottomed at 71.79% in Q4 2021.
  • The 5-year median for Net Margin is 0.29% (2023), against an average of 5.59%.
  • The largest annual shift saw Net Margin soared 7681bps in 2022 before it tumbled -4568bps in 2023.
  • A 5-year view of Net Margin shows it stood at 26.49% in 2020, then tumbled by -171bps to 71.79% in 2021, then skyrocketed by 107bps to 5.02% in 2022, then plummeted by -106bps to 0.29% in 2023, then plummeted by -225bps to 0.94% in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Net Margin are 0.94% (Q3 2024), 1.46% (Q2 2024), and 0.84% (Q1 2024).